cytekbio.com - CTKB Company Short-Term Debt

Cytek Biosciences (CTKB) - corporate logo

Cytek Biosciences, Inc. (CTKB) is developing biomedical innovations that are not restricted by trade sanctions and maintain a global status. High profitability is achieved through the sale of software and reagents for high-cost equipment. The current 0.01 metric confirms the effectiveness of this strategy. The price action history complements data regarding transparent asset management following the merger with Luminex and the strong engineering expertise of the leadership.

CTKB (Cytek Biosciences) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Cytek Corp - analytical breakdowns and key metrics (CTKB)

- price and consensus price forecast:
Stock Price Cytek Biosciences|CTKB - Analyst Consensus Forecast
- market capitalization data:
Market Value Cytek Biosciences, Inc.|CTKB - Business Value
- book capitalization data:
Book Value per Share Cytek Biosciences|CTKB - Book Capitalization|Market Value to Book Value Ratio cytekbio.com|CTKB - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Cytek Biosciences, Inc.|CTKB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Cytek Biosciences, Inc.|CTKB - Company Total Debt Obligations|Debts to Book Capitalization Cytek Biosciences, Inc.|CTKB - Long-Term Debt Volume|Company Short-Term Debt Cytek Biosciences
Analysis of all company metrics:Cytek Biosciences CTKB
Finished products of Cytek Biosciences, Inc.

The stability of liabilities determines the long-term solvency of Cytek Biosciences, Inc. (CTKB). This metric aggregates the total of all loans maturing within one year, reflecting the current debt load. The dynamics of short-term debt financing allow for tracking the payment schedule and assessing liquidity. An increase in this indicator signals a growing dependence on external capital. For Cytek Biosciences, Inc. (CTKB), this is critical due to the costs of procuring components from third-party suppliers.

Competitor analysis for Cytek Biosciences, Inc.

Agilent - Company Short-Term Debts|DGX: Company Short-Term Debts|Company Short-Term Debt Illumina Corp|Exact Sciences Inc. (EXAS) - Company Short-Term Indebtedness|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts BIO|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt Sotera Health Corp SHC|QDEL: Company Current Liabilities|OPKO Health Corp. - Short-Term Debt|Company Short-Term Debt CDNA (CareDx, Inc.)|MRVI - Short-Term Debt Volume|Fulgent Genetics - Company Short-Term Debts|LAB (Standard BioTools Inc) - Short-Term Debt Volume|OSUR: Company Short-Term Debt|Short-Term Debt Volume Exagen Diagnostics|Company Short-Term Debts MDXH (MDxHealth SA)|Company Current Liabilities luciddx.com LUCD|PRE: Company Current Liabilities|IMDX - Short-Term Debt|Company Current Liabilities Trinity Biotech Corp TRIB|PRPH - Amount of Current Liabilities|Company Short-Term Debts AIMD|CODX (codiagnostics.com) - Short-Term Debt|HSCS (HeartSciences) - Company Short-Term Debt|Company Short-Term Debts Biomerica Inc. (BMRA)|Cardio Diagnostics (CDIO) - Company Current Liabilities|Company Short-Term Loans and Borrowings Virax Biolabs Corp (VRAX)|Company Short-Term Debts Bluejay Diagnostics BJDX|Company Short-Term Debt aspirawh.com AWH|Company Short-Term Debts AXDX (Accelerate Diagnostics, Inc.)|CNTG: Short-Term Debt Volume|Company Short-Term Debt ENZ|FRES (Fresh2 Group) - Short-Term Debt|GENE: Company Short-Term Debt|Short-Term Debt Volume 23andme.com|Company Short-Term Debts PMD (Psychemedics Corporation)